MedTrace Logo

Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly

NCT05249335 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 256

Last updated 2022-02-21

No results posted yet for this study

Summary

This study compares the effectiveness and stability of intestinal tablet (OST), an oral sulfate table (OST), developed in the form of pills, with 2L-PEG/Asc for examinees aged 70 or older who are scheduled for colonoscopy.

Conditions

  • Colonic Disease
  • Intestinal Disease

Interventions

DRUG

OST

The subject will receive Orafang for colonoscopy

DRUG

2L-PEG/Asc

The subject will receive 2L-PEG/Asc for colonoscopy

Sponsors & Collaborators

  • Pharmbio Korea Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Cha Jaemyeong, M.D, Ph.D · Kyung Hee University Hospital at Gangdong

  • Gang Hoseok, M.D, Ph.D · HALLYM UNIV. MEDICAL CENTER

  • Seo Geomseok, M.D, Ph.D · Wonkwang University Hospital

  • Jeong Yunho, M.D, Ph.D · Soon Chun Hanyang University College of Medicine

  • Na Suyeong, M.D, Ph.D · Incheon St.Mary's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2024-02-29
Completion
2024-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05249335 on ClinicalTrials.gov